Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection
2003 ◽
Vol 71
(3)
◽
pp. 220-214
◽
2010 ◽
Vol 16
(6)
◽
pp. 809-817
◽
2007 ◽
Vol 38
(2)
◽
pp. 146-148
◽
2009 ◽
Vol 15
(7)
◽
pp. 886-887
◽
2017 ◽
Vol 23
(12)
◽
pp. 916-923
◽
2017 ◽
Vol 22
(3)
◽
pp. 132-136